19.14
前日終値:
$18.39
開ける:
$18.54
24時間の取引高:
3.20M
Relative Volume:
1.28
時価総額:
$2.45B
収益:
$642.82M
当期純損益:
$-43.54M
株価収益率:
-54.75
EPS:
-0.3496
ネットキャッシュフロー:
$130.12M
1週間 パフォーマンス:
+14.68%
1か月 パフォーマンス:
+1.32%
6か月 パフォーマンス:
+53.24%
1年 パフォーマンス:
+84.22%
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, TEM, BTSG, HQY, MMED
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TXG
10 X Genomics Inc
|
19.14 | 2.35B | 642.82M | -43.54M | 130.12M | -0.3496 |
|
VEEV
Veeva Systems Inc
|
185.23 | 30.26B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
49.14 | 8.40B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
42.10 | 7.92B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.64 | 6.84B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
MMED
Minimed Group Inc
|
17.10 | 4.65B | 0 | 0 | 0 | 0.00 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 開始されました | Piper Sandler | Neutral |
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
Cathie Wood’s ARK sells Bullish stock, buys more 10X Genomics By Investing.com - Investing.com India
These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool
10x Genomics Stock Analysis: Recent Gains vs. Long-Term Growth Challenges | 2026News and Statistics - IndexBox
10X Genomics Hits Day High with 8.39% Surge Amid Market Volatility - Markets Mojo
ARK Investment Increases Stake in 10x Genomics (TXG) with Major Purchase - GuruFocus
Cathie Wood’s ARK adds 10x Genomics stock, trims Arcturus - Investing.com
10X Genomics Stock Hits Day Low of $15.90 Amid Price Pressure - Markets Mojo
10x Genomics Inc Class A Trade Ideas — LSX:A2PPQJ - TradingView
10x Genomics Inc (TXG) Trading Down 10.96% on Mar 16 - GuruFocus
10x Genomics Shares Drop 10.9% Amid Market Volatility - National Today
10x Genomics (NASDAQ:TXG) Shares Down 10.9%Here's Why - MarketBeat
10x Genomics (TXG) Shares Drop Nearly 14% - GuruFocus
TXG SEC Filings10X Genomics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings - Investing.com Nigeria
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells - Investing.com
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells By Investing.com - Investing.com South Africa
10X Genomics Experiences Evaluation Revision Amid Mixed Market Signals and Performance Metrics - Markets Mojo
10X Genomics Stock Hits Day Low of $18.80 Amid Price Pressure - Markets Mojo
Dynamic Technology Lab Private Ltd Has $1.13 Million Stock Holdings in 10x Genomics $TXG - MarketBeat
Level Four Advisory Services LLC Acquires New Position in 10x Genomics $TXG - MarketBeat
Smart Money: Can 10x Genomics Inc grow without dilutionWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Risk Report: Can 10x Genomics Inc grow without dilutionJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
10x Genomics $TXG Shares Bought by JPMorgan Chase & Co. - MarketBeat
Citigroup Inc. Increases Holdings in 10x Genomics $TXG - MarketBeat
Citigroup Boosts Stake in 10x Genomics - National Today
ARK Investment Cuts Stake in 10x Genomics - National Today
10x genomics CEO Saxonov sells $367,096 in shares - Investing.com UK
10x Genomics $TXG Shares Sold by ARK Investment Management LLC - MarketBeat
Amova Asset Management Americas Inc. Has $62.86 Million Stock Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
TXG Technical Analysis & Stock Price Forecast - Intellectia AI
10x Genomics $TXG Position Lifted by Vanguard Group Inc. - MarketBeat
10X Genomics Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Breaking Down 10x Genomics: 11 Analysts Share Their Views - Sahm
Commit To Buy 10x Genomics At $15, Earn 20.6% Annualized Using Options - Nasdaq
TXG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Ascendis Pharma (ASND) and Roche Holding AG (OtherRHHVF) - The Globe and Mail
Stifel Nicolaus Boosts 10x Genomics Price Target to $25 - National Today
Major RSU grant to 10x Genomics (TXG) CEO Serge Saxonov - Stock Titan
88,816 RSUs awarded to 10x Genomics (TXG) director Hindson - Stock Titan
10x Genomics (TXG) CFO granted 106,579 RSUs in new equity award - Stock Titan
TXG affiliate files Form 144: proposed Class A Common sale (NASDAQ: TXG) - Stock Titan
10X Genomics Hits Day High with Strong 12.56% Intraday Surge - Markets Mojo
10x Genomics (NASDAQ:TXG) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Is It Time To Reassess 10x Genomics (TXG) After Its 1 Year Share Price Surge - Yahoo Finance
10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is 10x Genomics Inc.’s ROIC above industry averageTrade Performance Summary & AI Driven Price Forecasts - mfd.ru
Insider Sell: Sarah Teichmann Sells Shares of 10x Genomics Inc (TXG) - GuruFocus
Director at 10x Genomics (TXG) sells 7,579 shares under 10b5-1 plan - Stock Titan
Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge - simplywall.st
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):